FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
Odevixibat, 501692-44-0, Odevixibat Intermediate 15570-12-4, stock 443.1g, white powder, assay by HPLC 98.5%, HNMR, LCMS we supply. |
Odevixibat, 501692-44-0, Odevixibat Intermediate 212579-58-3, stock 343.8g, white powder, assay by HPLC 98.5%, HNMR, LCMS we supply. |
Odevixibat, 501692-44-0, Odevixibat Intermediate 212579-59-4, stock 187.8g, white powder, assay by HPLC 99.4%, HNMR, LCMS we supply. |
Odevixibat, 501692-44-0, Odevixibat Intermediate /, stock 639.8g, white powder, assay by HPLC 98.7%, HNMR, LCMS we supply. |
Odevixibat, 501692-44-0, Odevixibat Intermediate /, stock 927.7g, white powder, assay by HPLC 98.9%, HNMR, LCMS we supply. |
Odevixibat, 501692-44-0, Odevixibat Intermediate 501692-83-7, stock 549.8g, white powder, assay by HPLC 99.2%, HNMR, LCMS we supply. |
Odevixibat, 501692-44-0, Odevixibat Intermediate 501692-60-0, stock 110.5g, white powder, assay by HPLC 98.3%, HNMR, LCMS we supply. |
Odevixibat, 501692-44-0, Odevixibat Intermediate 501692-63-3, stock 207.4g, white powder, assay by HPLC 99.7%, HNMR, LCMS we supply. |
Odevixibat, 501692-44-0, Odevixibat Intermediate 501692-32-6, stock 588.8g, white powder, assay by HPLC 99.2%, HNMR, LCMS we supply. |
Odevixibat, 501692-44-0, Odevixibat Intermediate 501692-31-5, stock 568.8g, white powder, assay by HPLC 98.2%, HNMR, LCMS we supply. |
Odevixibat, 501692-44-0, Odevixibat Intermediate 91462-82-7, stock 292.3g, white powder, assay by HPLC 99.5%, HNMR, LCMS we supply. |
Odevixibat, 501692-44-0, Odevixibat Intermediate 22818-40-2, stock 825.1g, white powder, assay by HPLC 99.8%, HNMR, LCMS we supply. |
Odevixibat, 501692-44-0, Odevixibat Intermediate /, stock 997.3g, white powder, assay by HPLC 98.5%, HNMR, LCMS we supply. |